MolNFT v1 · #115377 · protein
Crystal structure of USP18
5CHT · Ubl carboxyl-terminal hydrolase 18: “Crystal structure of USP18”. X-ray diffraction, 1 ligand (ZN), 8 pockets (best druggability 0.70). MolNFT v1 #115377 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5CHT
- Type
- protein
- Length
- 608 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Ubl carboxyl-terminal hydrolase 18
- EC
- 3.4.19.-
- UniProt
- Q9WTV6
- Ligands
- ZN
- Pockets
- 8 · best druggability 0.70
Structure
x-ray diffraction · 2 distinct chains · 30% helix, 30% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Ubl carboxyl-terminal hydrolase 18 (EC 3.4.19.-) | protein | 308 | 30% helix, 30% strand | Q9WTV6 |
| B | Ubl carboxyl-terminal hydrolase 18 (EC 3.4.19.-) | protein | 300 | 30% helix, 30% strand | Q9WTV6 |
Ligands and binding sites
- ZN · Zinc ion · metal · 3 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 444 | 0.70 | 0.81 | 63 | empty |
| 2 | 354 | 0.65 | 0.80 | 44 | empty |
| 3 | 56 | 0.50 | 0.86 | 13 | empty |
| 4 | 98 | 0.41 | 0.77 | 15 | empty |
| 5 | 66 | 0.40 | 0.80 | 19 | empty |
Interfaces
1 interface between chains.
- A–B · 976 Ų buried · 5 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9WTV6
- Elsewhere: RCSB PDB 5CHT · PDBe 5CHT · UniProt Q9WTV6
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.